Why Did Shares of HEXO Plunge 28% Yesterday?

On Monday, HEXO Corp. (HEXO) reported second-quarter fiscal 2020 financial results before the market opened. Despite its tremendous rally last week, the stock plummeted 28%…

Read more »

These 5 Pot Stocks Are Up Over 100% in a Week, but Only 1 Is Worth Buying

To say that the stock market has been volatile would be a brutal understatement. The week prior to last, the CBOE Volatility Index, or VIX, which measures the expected volatility of S&P

Read more »

3 Cannabis Stocks Investors Should Watch as Markets Rebound

The coronavirus outbreak has caused havoc in global financial markets. As of March 23, the S&P 500 Index and the Dow Jones Industrial Average had fallen by 35.4% and 38.4%

Read more »

Is Innovative Industrial Properties (IIPR) a Great Cannabis Stock to Buy During This Volatility?

Just a week ago in our most recent article about Innovative Industrial Properties, we said that at $40 per share, we believed that shares were attractive. Fast forward 7 days later

Read more »

Should cannabis investors be more bullish?

The cannabis industry has gone through a rough period lately. After building extremely high expectations in 2018 with the legalization of recreational marijuana in Canada, marijuana stocks suffered significant losses

Read more »

Should You Avoid Pot Stocks Altogether During the Coronavirus Bear Market?

Last year was a challenging year for most cannabis companies, with shareholders becoming fed up with the continued losses that many industry giants were reporting. While some held out hope

Read more »

Is This the Next Big Cannabis IPO?

It may not be an opportune time for companies to go public, but don’t tell that to former Canopy Growth (NYSE:CGC) CEO Bruce Linton. Linton is still involved in the cannabis industry through Vireo

Read more »

This Pot Stock Could Benefit From a Recession

While the coronavirus collapse has hit the market hard, one pot stock could actually gain from the turmoil. When cannabis stocks were surging in 2018, investors were expecting growth across the board.

Read more »

Will Tilray (TLRY) Rebound From All-time Lows?

It has been a slippery slope for Tilray (TLRY) ever since the stock hit $300 per share back in 2018.  So far this week, TLRY has plunged more than 25%,

Read more »

Better Buy: GW Pharmaceuticals (GWPH) vs. Corbus Pharmaceuticals (CRBP)

Don’t call GW Pharmaceuticals (NASDAQ:GWPH) and Corbus Pharmaceuticals (NASDAQ:CRBP) “pot stocks.” These legitimate drug developers seek to harness the body’s endocannibinoid pathways to treat serious diseases…

Read more »